Payment overview · 2025
General Payments
$253.76
14 reported records · 5 companies
Healthcare provider profile · identity verified
Franklin David Chambers, M.D.
Allopathic & Osteopathic Physicians|Family Medicine · DUMAS, AR · NPI 1245286442
Verified facts
What the public records show
CMS Open Payments records show Franklin David Chambers, M.D. received $253.76 in general payments during 2025 across 14 reported records.
GlaxoSmithKline, LLC. accounted for 43.5% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 6 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Jardiance, Trelegy Ellipta.
Boehringer Ingelheim Pharmaceuticals, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 123636 records involving 49438 distinct recipient NPIs. Public Medicare Part D data also shows 118 claims for Jardiance by this doctor in 2024.
Boehringer Ingelheim Pharmaceuticals, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYNJARDY as an associated drug or biological on 33 records involving 33 distinct recipient NPIs. Public Medicare Part D data also shows 97 claims for Synjardy by this doctor in 2024.
GlaxoSmithKline, LLC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRELEGY ELLIPTA as an associated drug or biological on 131532 records involving 37148 distinct recipient NPIs. Public Medicare Part D data also shows 307 claims for Trelegy Ellipta by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| GlaxoSmithKline, LLC. | Unresolved — no canonical attribution shown | $110.46 | 43.5% | 7 | 2025 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | Unresolved — no canonical attribution shown | $65.50 | 25.8% | 3 | 2025 |
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $35.58 | 14.0% | 2 | 2025 |
| Axsome Therapeutics, Inc. | Unresolved — no canonical attribution shown | $23.79 | 9.4% | 1 | 2025 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | Unresolved — no canonical attribution shown | $18.43 | 7.3% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $253.76 | 14 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| TRELEGY ELLIPTA Normalized: trelegy ellipta |
Drug | GlaxoSmithKline, LLC. | $110.46 | 7 | 2025 |
Source payment records
|
|||||
| CAPLYTA Normalized: caplyta |
Drug | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $65.50 | 3 | 2025 |
Source payment records
|
|||||
| The Cologuard Plus Collection Kit Normalized: the cologuard plus collection kit |
Device | Exact Sciences Corporation | $35.58 | 2 | 2025 |
Source payment records
|
|||||
| AREXVY Normalized: arexvy |
Biological | GlaxoSmithKline, LLC. | $30.70 | 2 | 2025 |
Source payment records
|
|||||
| Auvelity Normalized: auvelity |
Drug | Axsome Therapeutics, Inc. | $23.79 | 1 | 2025 |
Source payment records
|
|||||
| JARDIANCE Normalized: jardiance |
Drug | Boehringer Ingelheim Pharmaceuticals, Inc. | $18.43 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| JARDIANCE jardiance |
2025 | Jardiance | 2024 | 118 | exact normalized | Medicare Part D |
| TRELEGY ELLIPTA trelegy ellipta |
2025 | Trelegy Ellipta | 2024 | 307 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. Exact reporting entity; no affiliate inference |
2025 | JARDIANCE open payments reported associated product |
CMS Open Payments — General Payments 123636 supporting records · 49438 recipient NPIs · example record 1221811583 |
Jardiance · 2024 Exact normalized brand match · 1 Part D row |
118 | 26 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Exact reporting entity; no affiliate inference |
2025 | SYNJARDY open payments reported associated product |
CMS Open Payments — General Payments 33 supporting records · 33 recipient NPIs · example record 1222725005 |
Synjardy · 2024 Exact normalized brand match · 1 Part D row |
97 | 23 |
| GlaxoSmithKline, LLC. Exact reporting entity; no affiliate inference |
2025 | TRELEGY ELLIPTA open payments reported associated product |
CMS Open Payments — General Payments 131532 supporting records · 37148 recipient NPIs · example record 1190332369 |
Trelegy Ellipta · 2024 Exact normalized brand match · 1 Part D row |
307 | 98 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Pantoprazole Sodium | Pantoprazole Sodium | 734 | 180 |
| Gabapentin | Gabapentin | 702 | 208 |
| Levothyroxine Sodium | Levothyroxine Sodium | 660 | 137 |
| Tizanidine Hcl | Tizanidine Hcl | 627 | 206 |
| Losartan Potassium | Losartan Potassium | 607 | 151 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 462 | 196 |
| Amlodipine Besylate | Amlodipine Besylate | 458 | 114 |
| Celecoxib | Celecoxib | 437 | 136 |
| Montelukast Sodium | Montelukast Sodium | 421 | 132 |
| Duloxetine Hcl | Duloxetine Hcl | 395 | 97 |
| Atorvastatin Calcium | Atorvastatin Calcium | 377 | 90 |
| Potassium Chloride | Potassium Chloride | 355 | 91 |
| Tamsulosin Hcl | Tamsulosin Hcl | 352 | 91 |
| Fluticasone Propionate | Fluticasone Propionate | 351 | 132 |
| Furosemide | Furosemide | 350 | 90 |
| Simvastatin | Simvastatin | 315 | 76 |
| Metoprolol Tartrate | Metoprolol Tartrate | 307 | 71 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 307 | 98 |
| Quetiapine Fumarate | Quetiapine Fumarate | 299 | 71 |
| Atenolol | Atenolol | 289 | 78 |
| Clonidine Hcl | Clonidine Hcl | 270 | 89 |
| Metformin Hcl | Metformin Hcl | 268 | 91 |
| Pregabalin | Pregabalin | 255 | 89 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 244 | 75 |
| Clopidogrel | Clopidogrel Bisulfate | 237 | 55 |
| Zolpidem Tartrate | Zolpidem Tartrate | 227 | 34 |
| Carvedilol | Carvedilol | 225 | 56 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 219 | 96 |
| Omeprazole | Omeprazole | 218 | 50 |
| Meloxicam | Meloxicam | 212 | 84 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 205 | 105 |
| Azithromycin | Azithromycin | 201 | 166 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 175 | 32 |
| Ozempic | Semaglutide | 174 | 40 |
| Metoprolol Succinate | Metoprolol Succinate | 172 | 39 |
| Terazosin Hcl | Terazosin Hcl | 166 | 42 |
| Sucralfate | Sucralfate | 164 | 51 |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 160 | 63 |
| Lorazepam | Lorazepam | 157 | 60 |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 145 | 26 |
| Hydralazine Hcl | Hydralazine Hcl | 143 | 37 |
| Estradiol | Estradiol | 142 | 38 |
| Amitriptyline Hcl | Amitriptyline Hcl | 138 | 27 |
| Fluconazole | Fluconazole | 138 | 97 |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 133 | 32 |
| Ondansetron Odt | Ondansetron | 132 | 59 |
| Jardiance | Empagliflozin | 118 | 26 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 115 | 26 |
| Naproxen | Naproxen | 114 | 39 |
| Nifedipine Er | Nifedipine | 114 | 24 |
| Ventolin Hfa | Albuterol Sulfate | 112 | 51 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 109 | 66 |
| Allopurinol | Allopurinol | 108 | 26 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 108 | 74 |
| Ibuprofen | Ibuprofen | 105 | 59 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 101 | 29 |
| Eliquis | Apixaban | 101 | 29 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 99 | 23 |
| Synjardy | Empagliflozin/Metformin Hcl | 97 | 23 |
| Trazodone Hcl | Trazodone Hcl | 97 | 28 |
| Mounjaro | Tirzepatide | 96 | 15 |
| Linzess | Linaclotide | 92 | 36 |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 91 | 27 |
| Raloxifene Hcl | Raloxifene Hcl | 90 | 22 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 89 | 73 |
| Lactulose | Lactulose | 89 | 56 |
| Tramadol Hcl | Tramadol Hcl | 88 | 46 |
| Hydrochlorothiazide | Hydrochlorothiazide | 87 | 20 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 87 | 36 |
| Fluoxetine Hcl | Fluoxetine Hcl | 86 | 24 |
| Escitalopram Oxalate | Escitalopram Oxalate | 85 | 22 |
| Spironolactone | Spironolactone | 78 | 15 |
| Janumet | Sitagliptin Phos/Metformin Hcl | 76 | 14 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 75 | 15 |
| Famotidine | Famotidine | 74 | 15 |
| Clindamycin Hcl | Clindamycin Hcl | 73 | 56 |
| Lisinopril | Lisinopril | 73 | 23 |
| Bumetanide | Bumetanide | 72 | 30 |
| Entresto | Sacubitril/Valsartan | 70 | 15 |
| Farxiga | Dapagliflozin Propanediol | 70 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 70 | 29 |
| Levetiracetam | Levetiracetam | 69 | 12 |
| Januvia | Sitagliptin Phosphate | 67 | 16 |
| Symbicort | Budesonide/Formoterol Fumarate | 67 | 26 |
| Buspirone Hcl | Buspirone Hcl | 66 | 15 |
| Citalopram Hbr | Citalopram Hydrobromide | 64 | 16 |
| Temazepam | Temazepam | 64 | 16 |
| M-Natal Plus | Pnv,calcium 72/Iron/Folic Acid | 62 | 25 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 61 | 53 |
| Terbinafine Hcl | Terbinafine Hcl | 61 | 22 |
| Colchicine | Colchicine | 56 | 22 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 55 | 36 |
| Diazepam | Diazepam | 55 | 15 |
| Gemfibrozil | Gemfibrozil | 55 | 17 |
| Valsartan | Valsartan | 53 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 52 | 14 |
| Metformin Hcl Er | Metformin Hcl | 51 | 15 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 51 | 12 |
| Amoxicillin | Amoxicillin | 50 | 34 |
| Bupropion Xl | Bupropion Hcl | 49 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 49 | 22 |
| Nitroglycerin | Nitroglycerin | 49 | 19 |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 47 | suppressed |
| Ezetimibe | Ezetimibe | 46 | 12 |
| Pravastatin Sodium | Pravastatin Sodium | 46 | 13 |
| Finasteride | Finasteride | 45 | suppressed |
| Lansoprazole | Lansoprazole | 45 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 45 | 14 |
| Risperidone | Risperidone | 45 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 45 | 11 |
| Bupropion Hcl Sr | Bupropion Hcl | 44 | 19 |
| Digoxin | Digoxin | 44 | suppressed |
| Mupirocin | Mupirocin | 44 | 27 |
| Xarelto | Rivaroxaban | 44 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 42 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 42 | 21 |
| Sertraline Hcl | Sertraline Hcl | 42 | 15 |
| Baclofen | Baclofen | 41 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 40 | 15 |
| Donepezil Hcl | Donepezil Hcl | 39 | suppressed |
| Levemir Flexpen | Insulin Detemir | 39 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 39 | 16 |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 37 | 12 |
| Neomycin-Polymyxin-Hydrocort | Neomycin/Polymyxin B/Hydrocort | 36 | 30 |
| Clorazepate Dipotassium | Clorazepate Dipotassium | 35 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 35 | 12 |
| Sumatriptan Succinate | Sumatriptan Succinate | 35 | suppressed |
| Glipizide | Glipizide | 34 | 11 |
| Morphine Sulfate | Morphine Sulfate | 34 | 27 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 33 | suppressed |
| Glipizide-Metformin | Glipizide/Metformin Hcl | 33 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 33 | 14 |
| Prednisone | Prednisone | 33 | 17 |
| Topiramate | Topiramate | 32 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 32 | 21 |
| Aripiprazole | Aripiprazole | 31 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 31 | suppressed |
| Alprazolam | Alprazolam | 30 | 15 |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 30 | suppressed |
| Lubiprostone | Lubiprostone | 30 | suppressed |
| Butorphanol Tartrate | Butorphanol Tartrate | 29 | suppressed |
| Fesoterodine Fumarate Er | Fesoterodine Fumarate | 29 | suppressed |
| Glimepiride | Glimepiride | 29 | suppressed |
| Latanoprost | Latanoprost | 29 | suppressed |
| Methylprednisolone | Methylprednisolone | 29 | 28 |
| Cefuroxime | Cefuroxime Axetil | 28 | 26 |
| Dicyclomine Hcl | Dicyclomine Hcl | 28 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 28 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 28 | suppressed |
| Atenolol-Chlorthalidone | Atenolol/Chlorthalidone | 26 | suppressed |
| Nystatin | Nystatin | 26 | 12 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 26 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 25 | 11 |
| Lamotrigine | Lamotrigine | 25 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 25 | suppressed |
| Lidocaine | Lidocaine | 24 | suppressed |
| Penicillin V Potassium | Penicillin V Potassium | 24 | 15 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 23 | suppressed |
| Lidocaine Hcl Viscous | Lidocaine Hcl | 23 | 13 |
| Mirtazapine | Mirtazapine | 23 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 23 | suppressed |
| Nurtec Odt | Rimegepant Sulfate | 22 | suppressed |
| Trulicity | Dulaglutide | 22 | suppressed |
| Ketoconazole | Ketoconazole | 21 | 13 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 20 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 20 | suppressed |
| Gemtesa | Vibegron | 20 | suppressed |
| Myrbetriq | Mirabegron | 20 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 20 | suppressed |
| Acebutolol Hcl | Acebutolol Hcl | 19 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 19 | suppressed |
| Bydureon Bcise | Exenatide Microspheres | 19 | suppressed |
| Chlorthalidone | Chlorthalidone | 19 | suppressed |
| Dilt-Xr | Diltiazem Hcl | 19 | suppressed |
| Gentamicin Sulfate | Gentamicin Sulfate | 19 | 12 |
| Comfort Ez Pen Needle | Pen Needle, Diabetic | 18 | suppressed |
| Humulin N | Insulin Nph Human Isophane | 18 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 18 | suppressed |
| Metronidazole | Metronidazole | 18 | 18 |
| Synthroid | Levothyroxine Sodium | 18 | suppressed |
| Carbamazepine | Carbamazepine | 17 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 17 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 17 | suppressed |
| Memantine Hcl | Memantine Hcl | 17 | suppressed |
| Febuxostat | Febuxostat | 16 | suppressed |
| Novolog Flexpen | Insulin Aspart | 16 | suppressed |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 15 | suppressed |
| Combigan | Brimonidine Tartrate/Timolol | 15 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 15 | suppressed |
| Lithium Carbonate | Lithium Carbonate | 15 | suppressed |
| Methocarbamol | Methocarbamol | 15 | suppressed |
| Vraylar | Cariprazine Hcl | 15 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 14 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 14 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 14 | suppressed |
| Ketorolac Tromethamine | Ketorolac Tromethamine | 14 | 13 |
| Novolog | Insulin Aspart | 14 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 14 | suppressed |
| Synjardy Xr | Empagliflozin/Metformin Hcl | 14 | suppressed |
| Armour Thyroid | Thyroid,pork | 13 | suppressed |
| Dutasteride | Dutasteride | 13 | suppressed |
| Enulose | Lactulose | 13 | suppressed |
| Humulin R | Insulin Regular, Human | 13 | suppressed |
| Metolazone | Metolazone | 13 | suppressed |
| Minoxidil | Minoxidil | 13 | suppressed |
| Olanzapine | Olanzapine | 13 | suppressed |
| Oseltamivir Phosphate | Oseltamivir Phosphate | 13 | 13 |
| Oxazepam | Oxazepam | 13 | suppressed |
| Alcohol Prep Pads | Alcohol Antiseptic Pads | 12 | suppressed |
| Clonazepam | Clonazepam | 12 | suppressed |
| Constulose | Lactulose | 12 | 12 |
| Fenofibrate | Fenofibrate Nanocrystallized | 12 | suppressed |
| Hydrocortisone | Hydrocortisone | 12 | suppressed |
| Lovastatin | Lovastatin | 12 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 12 | suppressed |
| Nyamyc | Nystatin | 12 | suppressed |
| Primidone | Primidone | 12 | suppressed |
| Propafenone Hcl Er | Propafenone Hcl | 12 | suppressed |
| Scopolamine | Scopolamine | 12 | suppressed |
| Sure Comfort | Syringe And Needle,insulin,1ml | 12 | suppressed |
| Verapamil Hcl | Verapamil Hcl | 12 | suppressed |
| Acyclovir | Acyclovir | 11 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 11 | suppressed |
| Arformoterol Tartrate | Arformoterol Tartrate | 11 | suppressed |
| Betamethasone Dipropionate | Betamethasone Dipropionate | 11 | suppressed |
| Creon | Lipase/Protease/Amylase | 11 | suppressed |
| Cyanocobalamin Injection | Cyanocobalamin (Vitamin B-12) | 11 | suppressed |
| Dulera | Mometasone/Formoterol | 11 | suppressed |
| Haloperidol Decanoate | Haloperidol Decanoate | 11 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 11 | suppressed |
| Klor-Con M20 | Potassium Chloride | 11 | suppressed |
| Medroxyprogesterone Acetate | Medroxyprogesterone Acetate | 11 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 11 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 11 | suppressed |
| Trueplus Pen Needle | Pen Needle, Diabetic | 11 | suppressed |
| Ubrelvy | Ubrogepant | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $253.76 · 14 records | GlaxoSmithKline, LLC. | AREXVY, Auvelity, CAPLYTA, JARDIANCE, TRELEGY ELLIPTA, The Cologuard Plus Collection Kit | 3 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Jardiance play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with Boehringer Ingelheim Pharmaceuticals, Inc.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error